PRIMARY HYPERCHOLESTEROLEMIA
Clinical trials for PRIMARY HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for PRIMARY HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Two-in-One pill tested to tackle major heart risk factors
Disease control CompletedThis study tested a new combination pill designed to treat two common conditions at once: high blood pressure and high cholesterol. It involved 156 adults with both conditions and compared the new pill's effectiveness and safety against standard treatments over 8 weeks. The goal …
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase: PHASE3 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Two-Pronged attack on high cholesterol shows promise
Disease control CompletedThis study observed nearly 1,840 real-world patients with high cholesterol who were prescribed a single pill containing two medications (atorvastatin and ezetimibe). The goal was to see how well and how safely this combination treatment worked over 24 weeks to lower 'bad' cholest…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Two drugs beat one in cholesterol battle
Disease control CompletedThis completed study tested if a two-drug combination (DW5421A/DW5421B) works better than a single drug (DW5421A) at lowering 'bad' LDL cholesterol in adults with high cholesterol or mixed lipid problems. About 184 participants were randomly assigned to take either the combinatio…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase: PHASE3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
First human test of new heart health drug combo
Knowledge-focused CompletedThis early-stage study tested how the body absorbs and processes a new combination drug called BR1018, intended for high blood pressure and high cholesterol. Researchers gave single doses to 60 healthy volunteers to measure drug levels in the blood and check for safety. The goal …
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Apr 02, 2026 04:11 UTC